Bioprocess Capital Costs
By Mark Warner, PE, Founder, Warner Advisors LLC Special to The Digest Discussion of biotechnology capital costs is often a controversial topic, on par with discussing politics at the Thanksgiving dinner table; why the facilities are so expensive and a disbelief of the forecasted costs. As a seasoned veteran in the battle, trust me when I […]














